C21 Investments Inc.

CWLXF Biotech & pharma
Mar 2026Revenue $32.6M/yrExpenses $30.3M/yr
No trend
Figures by year

Is C21 Investments profitable?

Yes. In the 12 months to Mar 2026, revenue was $32.6M and expenses $30.3M.

Fiscal year toRevenueExpensesOperating profit
Mar 2026$32.6M$30.3M$2.28M
Mar 2025$30.1M$28.8M$1.28M
Jan 2024$28.3M$26.8M$1.47M
Jan 2023$28.9M$24.9M$3.96M
Jan 2022$33.0M$23.2M$9.75M
Jan 2021$33.5M$24.2M$9.24M